Treatment of nmCRPC: comorbidities and DDIsIr al contenidoOncologíaTreatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactions28 Dec, 2023 David Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, Alejo Rodriguez-Vida. Expert Opin Drug Metab Toxicol. 2022 Sep;18(9):601-613.Related ContentDarolutamide + ADT + Docetaxel in mHSPC by SubgroupsCPHSmInforme SEOM de evaluación de darolutamida en CPRCnmCPRCnm